Alport Syndrome Latest Advances

Capsid Engineering of Adeno-Associated Viruses for Targeted Gene Therapy in Kidney Diseases.

Journal: Human gene therapy

Published: May 29, 2026

Sodium-Glucose Cotransporter 2 Inhibitors in Alport Syndrome: Emerging Clinical Evidence and Mechanistic Insights.

Journal: Kidney360

Published: May 28, 2026

Beyond Living Donor Kidney Transplantation in COL4 Nephropathy - A Real-World Clinical Dilemma in Light of Current Guidelines.

Journal: Balkan journal of medical genetics : BJMG

Published: May 18, 2026

Albuminuria drives hyperlipidemia in patients with Alport syndrome.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: May 15, 2026

An Alport variant illuminates the bioactivity of the collagen IV α565- α121 scaffold in Bowman's capsule.

Journal: bioRxiv : the preprint server for biology

Published: May 13, 2026

Kidney transplantation in Alport syndrome: A genotype-guided case series and literature review.

Journal: Turkish journal of surgery

Published: May 04, 2026

Coexistence of Proteinase 3 (PR3)-Positive Granulomatosis With Polyangiitis and Genetically Confirmed Alport Syndrome in a 31-Year-Old Female Patient: A Diagnostic and Management Challenge.

Journal: Cureus

Published: April 29, 2026

Phenotype of autosomal dominant Alport syndrome with a likely pathogenic heterozygous variant in the COL4A3 gene (Gly366Arg) and incidental teratozoospermia: A case report.

Journal: Anales del sistema sanitario de Navarra

Published: April 20, 2026

Unusual Glomerular Abnormalities in a Patient With Combined COL4A5-NPHS1 Variants.

Journal: Kidney medicine

Published: April 13, 2026

Pathogenic variants in COL4A3, COL4A4, JAG1, and NPHS2 genes in focal segmental glomerulosclerosis: Insights from targeted gene panel sequencing.

Journal: Molecular genetics and metabolism reports

Published: April 07, 2026

NBL1 associates with renal phenotypes in mice, but partial Nbl1 reduction does not ameliorate kidney disease.

Journal: American journal of physiology. Renal physiology

Published: March 30, 2026

Genetic heterogeneity correlated with phenotypic variability in 6 Chinese families with Alport syndrome.

Journal: Frontiers in genetics

Published: March 27, 2026

Alport Syndrome Latest Advances

Find the Latest Research About Alport Syndrome

Capsid Engineering of Adeno-Associated Viruses for Targeted Gene Therapy in Kidney Diseases.

Capsid Engineering of Adeno-Associated Viruses for Targeted Gene Therapy in Kidney Diseases.

Sodium-Glucose Cotransporter 2 Inhibitors in Alport Syndrome: Emerging Clinical Evidence and Mechanistic Insights.

Sodium-Glucose Cotransporter 2 Inhibitors in Alport Syndrome: Emerging Clinical Evidence and Mechanistic Insights.

Beyond Living Donor Kidney Transplantation in COL4 Nephropathy - A Real-World Clinical Dilemma in Light of Current Guidelines.

Beyond Living Donor Kidney Transplantation in COL4 Nephropathy - A Real-World Clinical Dilemma in Light of Current Guidelines.

Albuminuria drives hyperlipidemia in patients with Alport syndrome.

Albuminuria drives hyperlipidemia in patients with Alport syndrome.

An Alport variant illuminates the bioactivity of the collagen IV α565- α121 scaffold in Bowman's capsule.

An Alport variant illuminates the bioactivity of the collagen IV α565- α121 scaffold in Bowman's capsule.

Kidney transplantation in Alport syndrome: A genotype-guided case series and literature review.

Kidney transplantation in Alport syndrome: A genotype-guided case series and literature review.

Coexistence of Proteinase 3 (PR3)-Positive Granulomatosis With Polyangiitis and Genetically Confirmed Alport Syndrome in a 31-Year-Old Female Patient: A Diagnostic and Management Challenge.

Coexistence of Proteinase 3 (PR3)-Positive Granulomatosis With Polyangiitis and Genetically Confirmed Alport Syndrome in a 31-Year-Old Female Patient: A Diagnostic and Management Challenge.

Phenotype of autosomal dominant Alport syndrome with a likely pathogenic heterozygous variant in the COL4A3 gene (Gly366Arg) and incidental teratozoospermia: A case report.

Phenotype of autosomal dominant Alport syndrome with a likely pathogenic heterozygous variant in the COL4A3 gene (Gly366Arg) and incidental teratozoospermia: A case report.

Unusual Glomerular Abnormalities in a Patient With Combined COL4A5-NPHS1 Variants.

Unusual Glomerular Abnormalities in a Patient With Combined COL4A5-NPHS1 Variants.

Pathogenic variants in COL4A3, COL4A4, JAG1, and NPHS2 genes in focal segmental glomerulosclerosis: Insights from targeted gene panel sequencing.

Pathogenic variants in COL4A3, COL4A4, JAG1, and NPHS2 genes in focal segmental glomerulosclerosis: Insights from targeted gene panel sequencing.

NBL1 associates with renal phenotypes in mice, but partial Nbl1 reduction does not ameliorate kidney disease.

NBL1 associates with renal phenotypes in mice, but partial Nbl1 reduction does not ameliorate kidney disease.

Genetic heterogeneity correlated with phenotypic variability in 6 Chinese families with Alport syndrome.

Genetic heterogeneity correlated with phenotypic variability in 6 Chinese families with Alport syndrome.